Combinatorial Cytokine Code Generates Anti-Viral State in Dendritic Cells
暂无分享,去创建一个
[1] Eduardo Pauls,et al. Two Phases of Inflammatory Mediator Production Defined by the Study of IRAK2 and IRAK1 Knock-in Mice , 2013, The Journal of Immunology.
[2] T. Randall,et al. CD4+ T helper cells use CD154–CD40 interactions to counteract T reg cell–mediated suppression of CD8+ T cell responses to influenza , 2013, The Journal of experimental medicine.
[3] Paul G. Thomas,et al. Receptor interacting protein kinase 2-mediated mitophagy regulates inflammasome activation during virus infection , 2013, Nature Immunology.
[4] D. Zamboni,et al. NOD1 and NOD2 Signaling in Infection and Inflammation , 2012, Front. Immun..
[5] Xiaobo Zhou,et al. Cytokine combination therapy prediction for bone remodeling in tissue engineering based on the intracellular signaling pathway. , 2012, Biomaterials.
[6] Marion C Lanteri,et al. IL-1β Signaling Promotes CNS-Intrinsic Immune Control of West Nile Virus Infection , 2012, PLoS pathogens.
[7] D. Holmberg,et al. Adoptive Transfer of Immunomodulatory M2 Macrophages Prevents Type 1 Diabetes in NOD Mice , 2012, Diabetes.
[8] J. Kos,et al. Regulation of cathepsins S and L by cystatin F during maturation of dendritic cells. , 2012, European journal of cell biology.
[9] J. Batra,et al. Antimicrobial activity of human eosinophil granule proteins: involvement in host defence against pathogens , 2012, Critical reviews in microbiology.
[10] R. Albrecht,et al. The M Segment of the 2009 New Pandemic H1N1 Influenza Virus Is Critical for Its High Transmission Efficiency in the Guinea Pig Model , 2011, Journal of Virology.
[11] Peter O. Krutzik,et al. Structural Linkage between Ligand Discrimination and Receptor Activation by Type I Interferons , 2011, Cell.
[12] Jianhua Xiao,et al. The kinase activity of interleukin-1 receptor-associated kinase 2 is essential for lipopolysaccharide-mediated cytokine and chemokine mRNA stability and translation. , 2011, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.
[13] T. Waldmann,et al. Co-adjuvant effects of retinoic acid and IL-15 induce inflammatory immunity to dietary antigens , 2011, Nature.
[14] M. Suárez-Fariñas,et al. Resolved psoriasis lesions retain expression of a subset of disease-related genes. , 2011, The Journal of investigative dermatology.
[15] S. Watowich,et al. Mechanisms regulating dendritic cell specification and development , 2010, Immunological reviews.
[16] M. Belvisi,et al. TNFα and IFNγ synergistically enhance transcriptional activation of CXCL10 in human airway smooth muscle cells via STAT-1, NF-κB, and the transcriptional coactivator CREB-binding protein. , 2010, The Journal of biological chemistry.
[17] Nikesh Kotecha,et al. Web‐Based Analysis and Publication of Flow Cytometry Experiments , 2010, Current protocols in cytometry.
[18] I. Kim,et al. Leukotactin-1/CCL15 induces cell migration and differentiation of human eosinophilic leukemia EoL-1 cells through PKCδ activation , 2010, Molecular Biology Reports.
[19] B. Meskó,et al. Peripheral blood gene expression patterns discriminate among chronic inflammatory diseases and healthy controls and identify novel targets , 2010, BMC Medical Genomics.
[20] Lawrence Steinman,et al. T helper type 1 and 17 cells determine efficacy of interferon-β in multiple sclerosis and experimental encephalomyelitis , 2010, Nature Medicine.
[21] H. Wajant,et al. TRAIL signaling is mediated by DR4 in pancreatic tumor cells despite the expression of functional DR5 , 2010, Journal of Molecular Medicine.
[22] M. Pittelkow,et al. Combination cytokine therapy inhibits tumor growth by generation of tumor-specific T-cell responses in a murine melanoma model. , 2010, Cytokine.
[23] M. Kawaguchi,et al. IL-17A and IL-17F stimulate chemokines via MAPK pathways (ERK1/2 and p38 but not JNK) in mouse cultured mesangial cells: synergy with TNF-alpha and IL-1beta. , 2010, American journal of physiology. Renal physiology.
[24] G. de la Rosa,et al. Alarmins link neutrophils and dendritic cells. , 2009, Trends in immunology.
[25] Robert J. Vincent,et al. The beneficial effects of postinfarct cytokine combination therapy are sustained during long-term follow-up. , 2009, Journal of molecular and cellular cardiology.
[26] Thomas M. Moran,et al. Cutting Edge: Stealth Influenza Virus Replication Precedes the Initiation of Adaptive Immunity1 , 2009, The Journal of Immunology.
[27] J. Stübgen. Recombinant interferon-beta therapy and neuromuscular disorders , 2009, Journal of Neuroimmunology.
[28] E. Shin,et al. Immune‐based therapy for chronic hepatitis C , 2009, Journal of leukocyte biology.
[29] E. Pamer. Tipping the balance in favor of protective immunity during influenza virus infection , 2009, Proceedings of the National Academy of Sciences.
[30] M. Caligiuri,et al. Stem cell factor and interleukin-2/15 combine to enhance MAPK-mediated proliferation of human natural killer cells. , 2009, Blood.
[31] Edward D. Karoly,et al. Identification of gene biomarkers for respiratory syncytial virus infection in a bronchial epithelial cell line , 2008, Genomic Medicine.
[32] Boris M. Hartmann,et al. Antiviral-Activated Dendritic Cells: A Paracrine-Induced Response State1 , 2008, The Journal of Immunology.
[33] H. Baker,et al. The Addition of Tumor Necrosis Factor plus Beta Interferon Induces a Novel Synergistic Antiviral State against Poxviruses in Primary Human Fibroblasts , 2008, Journal of Virology.
[34] T. Schwartz,et al. Positive Versus Negative Modulation of Different Endogenous Chemokines for CC-chemokine Receptor 1 by Small Molecule Agonists through Allosteric Versus Orthosteric Binding* , 2008, Journal of Biological Chemistry.
[35] D. Donner,et al. Type 1 TNF Receptor Forms a Complex with and Uses Jak2 and c-Src to Selectively Engage Signaling Pathways That Regulate Transcription Factor Activity1 , 2008, The Journal of Immunology.
[36] G. McFadden,et al. RIG-I Mediates the Co-Induction of Tumor Necrosis Factor and Type I Interferon Elicited by Myxoma Virus in Primary Human Macrophages , 2008, PLoS pathogens.
[37] E. Coccia. IFN regulation and functions in myeloid dendritic cells. , 2008, Cytokine & growth factor reviews.
[38] D. Moskophidis,et al. Regulation of Immune Response and Inflammatory Reactions against Viral Infection by VCAM-1 , 2008, Journal of Virology.
[39] P. Preshaw,et al. The expanding family of interleukin‐1 cytokines and their role in destructive inflammatory disorders , 2007, Clinical and experimental immunology.
[40] S. Steer,et al. Evidence for an influence of chemokine ligand 3-like 1 (CCL3L1) gene copy number on susceptibility to rheumatoid arthritis , 2007, Annals of the rheumatic diseases.
[41] G. Uzé,et al. IL-28 and IL-29: newcomers to the interferon family. , 2007, Biochimie.
[42] C. Baldari,et al. Anthrax toxins inhibit immune cell chemotaxis by perturbing chemokine receptor signalling , 2007, Cellular microbiology.
[43] Clifford Liongue,et al. Cytokine receptor signaling through the Jak-Stat-Socs pathway in disease. , 2007, Molecular immunology.
[44] H. Pircher,et al. Analysis of CD127 and KLRG1 Expression on Hepatitis C Virus-Specific CD8+ T Cells Reveals the Existence of Different Memory T-Cell Subsets in the Peripheral Blood and Liver , 2006, Journal of Virology.
[45] J. Utikal,et al. Mphi1 and Mphi2 can be re-polarized by Th2 or Th1 cytokines, respectively, and respond to exogenous danger signals. , 2006, Immunobiology.
[46] T. Gingeras,et al. CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells , 2006, The Journal of experimental medicine.
[47] Thomas M. Moran,et al. Influenza Virus Evades Innate and Adaptive Immunity via the NS1 Protein , 2006, Journal of Virology.
[48] M. Ichinose,et al. Agents against cytokine synthesis or receptors. , 2006, European journal of pharmacology.
[49] N. Kajiwara,et al. CCL5-CCR5 interaction provides antiapoptotic signals for macrophage survival during viral infection , 2005, Nature Medicine.
[50] Y. Nakanishi,et al. Expression of B7-H1 and B7-DC on the airway epithelium is enhanced by double-stranded RNA. , 2005, Biochemical and biophysical research communications.
[51] A. Plet,et al. Natural, Proteolytic Release of a Soluble Form of Human IL-15 Receptor α-Chain That Behaves as a Specific, High Affinity IL-15 Antagonist1 , 2004, The Journal of Immunology.
[52] K. Dyer,et al. Eosinophil-derived neurotoxin (EDN), an antimicrobial protein with chemotactic activities for dendritic cells. , 2003, Blood.
[53] J. O’Shea,et al. The biology of IL-12: coordinating innate and adaptive immune responses. , 2003, Cytokine & growth factor reviews.
[54] A. García-Sastre,et al. Newcastle Disease Virus V Protein Is a Determinant of Host Range Restriction , 2003, Journal of Virology.
[55] P. Insel,et al. Inhibition of apoptosis in normal and transformed intestinal epithelial cells by cAMP through induction of inhibitor of apoptosis protein (IAP)-2 , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[56] G. Trinchieri,et al. Interleukin-12 and the regulation of innate resistance and adaptive immunity , 2003, Nature Reviews Immunology.
[57] Jun Zhang,et al. TL1A is a TNF-like ligand for DR3 and TR6/DcR3 and functions as a T cell costimulator. , 2002, Immunity.
[58] H. Mitsuya,et al. Identification of Amino Acid Residues Critical for LD78β, a Variant of Human Macrophage Inflammatory Protein-1α, Binding to CCR5 and Inhibition of R5 Human Immunodeficiency Virus Type 1 Replication* , 2002, The Journal of Biological Chemistry.
[59] A. Proudfoot. Chemokine receptors: multifaceted therapeutic targets , 2002, Nature Reviews Immunology.
[60] J. Chung,et al. IL-8 activates endothelial cell CXCR1 and CXCR2 through Rho and Rac signaling pathways. , 2001, American journal of physiology. Lung cellular and molecular physiology.
[61] S. Jiang,et al. Autocrine cell suicide in a Burkitt lymphoma cell line (Daudi) induced by interferon alpha: involvement of tumor necrosis factor as ligand for the CD95 receptor. , 2001, Blood.
[62] T. Huynh,et al. RANTES Activates Jak2 and Jak3 to Regulate Engagement of Multiple Signaling Pathways in T Cells* , 2001, The Journal of Biological Chemistry.
[63] M. Baggiolini,et al. The Ligands of CXC Chemokine Receptor 3, I-TAC, Mig, and IP10, Are Natural Antagonists for CCR3* , 2001, The Journal of Biological Chemistry.
[64] T. Malek,et al. Three Loops of the Common γ Chain Ectodomain Required for the Binding of Interleukin-2 and Interleukin-7* , 2000, The Journal of Biological Chemistry.
[65] D. Neumann,et al. The Membrane Form of the Type II IL-1 Receptor Accounts for Inhibitory Function1 , 2000, The Journal of Immunology.
[66] R. Doms,et al. CCR5 binds multiple CC-chemokines: MCP-3 acts as a natural antagonist. , 1999, Blood.
[67] A. D. de Vos,et al. Determination of residues involved in ligand binding and signal transmission in the human IFN-alpha receptor 2. , 1999, Journal of immunology.
[68] Stephen C. Peiper,et al. Identification of CXCR4 Domains That Support Coreceptor and Chemokine Receptor Functions , 1999, Journal of Virology.
[69] T. C. Wagner,et al. Formation of a uniquely stable type I interferon receptor complex by interferon beta is dependent upon particular interactions between interferon beta and its receptor and independent of tyrosine phosphorylation. , 1999, Biochemical and biophysical research communications.
[70] A. Rees,et al. Initial cytokine exposure determines function of macrophages and renders them unresponsive to other cytokines. , 1998, Journal of immunology.
[71] R. Hertzberg,et al. Identification of a Potent, Selective Non-peptide CXCR2 Antagonist That Inhibits Interleukin-8-induced Neutrophil Migration* , 1998, The Journal of Biological Chemistry.
[72] S. Nagata,et al. Apoptosis by Death Factor , 1997, Cell.
[73] C. Combadière,et al. Cloning and functional expression of CC CKR5, a human monocyte CC chemokine receptor selective for MIP‐1α, MIP‐1β, and RANTES , 1996, Journal of leukocyte biology.
[74] C. Mackay,et al. Molecular cloning and characterization of a human eotaxin receptor expressed selectively on eosinophils , 1996, The Journal of experimental medicine.
[75] C. Dinarello,et al. Biologic basis for interleukin-1 in disease. , 1996, Blood.
[76] S. Ziegler,et al. Interleukin-2 receptor gamma chain: a functional component of the interleukin-7 receptor. , 1993, Science.
[77] H. Nagafuchi,et al. Constitutive expression of IL-6 receptors and their role in the excessive B cell function in patients with systemic lupus erythematosus. , 1993, Journal of immunology.
[78] P. Jorens,et al. Cerebral arterial thrombosis preceding ulcerative colitis. , 1991, Stroke.
[79] H. Marquardt,et al. Molecular cloning, sequence analysis, and functional expression of a novel growth regulator, oncostatin M , 1989, Molecular and cellular biology.
[80] C. Eisenhart. The assumptions underlying the analysis of variance. , 1947, Biometrics.
[81] B. Torbett,et al. CLEC5A (MDL-1) is a novel PU.1 transcriptional target during myeloid differentiation. , 2011, Molecular immunology.
[82] I. Julkunen,et al. TLR ligands induce synergistic interferon-β and interferon-λ1 gene expression in human monocyte-derived dendritic cells. , 2011, Molecular immunology.
[83] Alex E. Lash,et al. Gene Expression Omnibus: NCBI gene expression and hybridization array data repository , 2002, Nucleic Acids Res..
[84] A. Zlotnik,et al. The biology of chemokines and their receptors. , 2000, Annual review of immunology.
[85] W. Fantl,et al. Signalling by receptor tyrosine kinases. , 1993, Annual review of biochemistry.
[86] Interferon (cid:1) induces mature dendritic cell apoptosis through caspase-11/caspase-3 activation , 2022 .